Monthly Archives: October 2020

The VP Sales of Cal-Maine Foods (NASDAQ: CALM) is Buying Shares

Yesterday, the VP Sales of Cal-Maine Foods (CALM – Research Report), Charles Jeff Hardin, bought shares of CALM for $76.54K. This recent transaction increases Charles Jeff Hardin’s holding in the company by 7.68% to a total of $1.08 million. This

What Did This CEO Just Do with Personal Shares of Shiloh Industries (Other OTC: SHLOQ)?

Today, the Interim CEO of Shiloh Industries (SHLOQ – Research Report), Cloyd Abruzzo, sold shares of SHLOQ for $3,448. This is Abruzzo’s first Sell trade following 3 Buy transactions. See today’s analyst top recommended stocks >> The company has a

Monday’s Midday Stock Update: Brainstorm Cell Therapeutics (BCLI), Aerie Pharma (AERI), Intercept Pharma (ICPT), SunPower (SPWR), Cleveland-Cliffs (CLF)

So far Monday, October 19, NASDAQ is down -5.75% and the S&P is down -3.7%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Brainstorm Cell Therapeutics (BCLI – Research Report), Aerie Pharma (AERI

Canaccord Genuity Remains a Buy on Y-Mabs Therapeutics (YMAB)

In a report released today, Arlinda Lee from Canaccord Genuity maintained a Buy rating on Y-Mabs Therapeutics (YMAB – Research Report), with a price target of $48.00. The company’s shares closed last Friday at $40.35. According to TipRanks.com, Lee is

Canaccord Genuity Sticks to Their Buy Rating for Agios Pharma (AGIO)

In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Agios Pharma (AGIO – Research Report), with a price target of $70.00. The company’s shares closed last Friday at $35.87. According to TipRanks.com, Newman is

The Chairman & Chief Executive Officer of Enghouse Systems (Other OTC: EGHSF) is Selling Shares

Today, the Chairman & Chief Executive Officer of Enghouse Systems (EGHSF – Research Report), Stephen J Sadler, sold shares of EGHSF for $3.09M. In addition to Stephen J Sadler, one other EGHSF executive reported Sell trades in the last month.